gantenerumab Articles
Roche and Lilly drugs chosen for major Washington University Alzheimer's prevention trial
11 October 2012
Roche's MAb gantenerumab seen to remove amyloid plaques from the brain of Alzheimer’s patients
12 October 2011
Showing 1-2 of 2 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
